Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 31

Trial Status

Completed1
Recruiting2

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT06228326Phase 1/2Recruiting
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Advanced CancerLung Cancer (NSCLC)Lung Cancer Metastatic+2 more
StudydirectorStart date: 2024-04-17
NCT05970497Phase 1/2Recruiting
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
CancerCutaneous MelanomaMelanoma Stage III+1 more
StudydirectorStart date: 2023-10-31
NCT04917874Phase 3Completed
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
DEB - Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis BullosaDystrophic Epidermolysis Bullosa+1 more
StudydirectorStart date: 2021-05-25

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06228326Phase 1/2StudyDirector

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Advanced CancerLung Cancer (NSCLC)Lung Cancer Metastatic+2 more
Recruiting
NCT05970497Phase 1/2StudyDirector

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

CancerCutaneous MelanomaMelanoma Stage III+1 more
Recruiting
NCT04917874Phase 3StudyDirector

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

DEB - Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis BullosaDystrophic Epidermolysis Bullosa+1 more
Completed

All 3 trials loaded